These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26392174)

  • 1. Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles.
    Ebrahimi HA; Javadzadeh Y; Hamidi M; Jalali MB
    Daru; 2015 Sep; 23(1):46. PubMed ID: 26392174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug.
    Ebrahimi HA; Javadzadeh Y; Hamidi M; Barzegar Jalali M
    J Pharm Pharmacol; 2016 Apr; 68(4):450-8. PubMed ID: 27114047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Curr Drug Deliv; 2010 Jan; 7(1):44-50. PubMed ID: 20044909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide.
    Vaghani SS; Patel MM
    Curr Drug Discov Technol; 2011 Jun; 8(2):126-35. PubMed ID: 21513486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation.
    Thakkar S; More N; Sharma D; Kapusetti G; Kalia K; Misra M
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1921-1930. PubMed ID: 31625774
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
    Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
    Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
    Trivino A; Gumireddy A; Chauhan H
    AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide.
    Kassem AA; Abd El-Alim SH; Basha M; Salama A
    Eur J Pharm Sci; 2017 Mar; 99():75-84. PubMed ID: 27998799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsion: for improved oral delivery of repaglinide.
    Akhtar J; Siddiqui HH; Fareed S; Badruddeen ; Khalid M; Aqil M
    Drug Deliv; 2016 Jul; 23(6):2026-34. PubMed ID: 27187792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of nanoparticle and nanoemulsion formulations containing repaglinide and determination of pharmacokinetic parameters in rats.
    Demirturk E; Ugur Kaplan AB; Cetin M; Dönmez Kutlu M; Köse S; Akıllıoğlu K
    Eur J Pharm Sci; 2024 Sep; 200():106844. PubMed ID: 38977205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
    Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.